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Abstract:
Introduction.' Todo:y, biological modifiers are used along with grofi materials to
occelerate bone regeneration and enhance quality and density of new bone. The atorvastatin
is one of this modifiers. Atorvastatin modified the rate of bone regeneration by affecting bone
regenerating agents and blood factors. The aim of this stu$t is evaluating the ffict of
atorvastatin in bone regeneration rate.
Methods.' In the current experimental animal stu$t, 4 groups (n:10 rats for each
group) were evaluated. Critical size defect (CSD) : 6 mn, was made in the rat calvriutrt
with trephine bur. Autograft with membrane, compose of FDBA and Atorvastatin with
membrane and FDBA with membrane were placed in every group of rats. One group was lefi
as control negative without arqt materials. Afier I and 2 montlu, animals were sacrificed and
the calvorium bone was stained with H & E for histopathologic and histomorphometrat
evaluation. New bone formation and presence of inJlammatory cells was evaluated for each
sample and described qualitatively.
Results.' In the autografi groqp rals, new bone formation rate was higher than the
other three groups and no sign of inJlommationwas observed in one and two montlts. Rate of
osteogenisis was similar both of groups of FDBA and FDBA combined with Atorvastatin,-
and was lower than autografi group- 77rc minimal bone regeneration rate was found at the
negative control group. Furthermore some degree of inflammation was found in FDBA
goup-
Conclusion : the results of our study revealed that atorvastatin in powder form had no
significant effect on regeneration rate.
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